V

    Veru Inc (VERU)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.80
    +0.18 (+6.67%)

    Market Cap: $44.76M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    51%(19/37)
    Avg Surprise
    -11.74%
    Streak
    4 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.12
    Range$-0.35 - $0.12
    2 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    Dec 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-N/A---
    Sep 26EST
    		-$-0.12---
    Jun 26
    		$-0.30$-0.32+6.25%Beat+43.4%
    Mar 26
    		$-0.13N/A+53.57%Beat+78.3%
    Dec 25
    		$-0.26$-0.47+44.68%Beat+63.4%
    Sep 25
    		$0.09$-0.06+258.73%Beat+273.1%
    Jun 25
    		$-0.53$-0.50-6.00%Miss+30.3%
    Mar 25
    		$-0.60$-0.50-20.00%Miss+34.1%
    Dec 24
    		$-0.71$-0.80+11.25%Beat-787.5%
    Sep 24
    		$-0.05$-0.08+35.00%Beat+96.2%
    Jun 24
    		$-0.76$-0.60-26.67%Miss+38.7%
    Mar 24
    		$-0.91$-1.50+39.33%Beat+78.9%
    Dec 23
    		$-0.08$-0.10+20.00%Beat+98.3%
    Sep 23
    		$-1.37$-2.35+41.70%Beat-168.6%
    Jun 23
    		$-1.24N/A+57.24%Beat+55.7%
    Mar 23
    		$-4.32$-3.30-30.91%Miss-140.0%
    Dec 22
    		$-4.60$-3.77-22.02%Miss-475.0%
    Sep 22
    		$-0.51$-0.30-70.00%Miss-920.0%
    Jun 22
    		$-2.80$-1.64-70.73%Miss-833.3%
    Mar 22
    		$-1.80$-1.15-56.52%Miss-350.0%
    Dec 21
    		$-0.80$-0.67-19.40%Miss-300.0%
    Sep 21
    		$-0.05$-0.09+44.44%Beat-266.7%
    Jun 21
    		$-0.30$-0.60+50.00%Beat+40.0%
    Mar 21
    		$-0.40$-0.30-33.33%Miss-300.0%
    Dec 20
    		$-0.20$-0.40+50.00%Beat+60.0%
    Sep 20
    		$0.03$-0.04+175.00%Beat+160.0%
    Jun 20
    		$-0.50$-0.32-56.25%Miss-25.0%
    Mar 20
    		$-0.10N/A+69.70%Beat+83.3%
    Dec 19
    		$-0.50$-0.23-117.39%Miss-66.7%
    Sep 19
    		$-0.05$-0.05+0.00%Beat+64.3%
    Jun 19
    		$-0.40$-0.45+11.11%Beat+73.3%
    Mar 19
    		$-0.60$-0.60+0.00%Beat+14.3%
    Dec 18
    		$-0.30$-0.04-650.00%Miss+25.0%
    Sep 18
    		$-0.14$-0.08-75.00%Miss+53.3%
    Jun 18
    		$-1.50$-0.80-87.50%Miss-2400.0%
    Mar 18
    		$-0.70$-0.50-40.00%Miss-1487.3%
    Dec 17
    		$-0.40$-0.30-33.33%Miss-562.3%
    Jun 17
    		$-0.30N/A+62.50%Beat-
    Mar 17
    		$-0.06$-0.04-50.00%Miss-
    Dec 16
    		$-0.04N/AN/ABeat-
    Sep 16
    		$-0.06N/AN/ABeat-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    No dividend payments in the selected period.
    View VERU's full dividend history

    Key Metrics

    Valuation
    P/E Ratio-4.67EV/EBITDA42.93x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-64.50%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio4.42xQuick Ratio4.42x
    Trading Statistics
    Beta-1.20Avg Volume254.29K
    52-Week High$4.5952-Week Low$2.05

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.67
    SMA 20$2.62
    SMA 50$2.61
    SMA 200$2.49
    EMA 10$2.69
    EMA 20$2.63
    EMA 50$2.59
    EMA 200$2.80

    MACD

    Line: 0.06Signal: 0.04Hist: 0.02

    ADX

    ADX: 23.4+DI: 26.1-DI: 16.4

    Aroon & PSAR

    Aroon Up40.0
    Aroon Down8.0
    PSAR$3.69

    Bollinger Bands

    Upper Band$2.95
    Lower Band$2.30
    %B Position2483%(Upper)
    Band Width0.78

    RSI (14-Day)

    Neutral
    58.4

    Momentum Oscillators

    Stoch %K66.1
    Stoch %D69.0
    Williams %R-11.8
    ROC (10d)6.5%
    Momentum0.17
    CCI (20d)71.7
    MFI (14d)51.2

    Volatility Measures

    ATR (14d)$0.16(5.6%)
    StdDev (20d)0.16
    Hist Vol81.1%(High)

    Volume Flow

    VWAP$2.74
    OBV114.7M
    AD Line47.8B
    CMF (20d)0.240

    Volume Metrics

    Avg Vol (20d)255.2K
    Vol Ratio1.0x
    VWMA (20d)$2.67

    Pivot Points

    R3$2.82
    R2$2.77
    R1$2.70
    Pivot Point$2.65
    S1$2.58
    S2$2.54
    S3$2.46

    Advanced Oscillators

    TSI10.58
    Ultimate Osc57.6
    KST90.42

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$247,064$0$0$0$6.66M$0$0$0$3.86M
    Cost of Revenue$0$0$0$28,573$0$0$0$3.97M$0$0$0$2.32M
    Gross Profit$0$0$0$-28,573$0$0$0$2.69M$0$0$0$1.54M
    Operating Expenses$7.71M$7.22M$5.42M$-1,166,793$7.55M$8.12M$10.25M$9.34M$10.55M$8.89M$7.39M$9.72M
    R&D$4.35M$3.15M$1.34M$2.92M$3.02M$3.93M$5.72M$3.29M$4.85M$2.99M$1.66M$3.94M
    SG&A$3.36M$4.07M$4.08M$4.54M$5.01M$5.16M$5.23M$6.25M$5.81M$5.90M$6.65M$6.77M
    Operating Income$-7,713,681$-7,218,968$-5,424,015$1.17M$-7,546,476$-8,122,232$-10,248,727$-9,342,962$-10,545,481$-8,888,791$-7,391,826$-8,176,134
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$-8,624,778$0$0$0$0$207,201
    Income Before Tax$-6,988,350$-3,092,550$-5,332,579$1.30M$-7,323,101$-7,852,393$-1,809,903$-8,549,400$-10,340,056$-8,703,099$-7,667,383$-7,574,623
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$557,492
    Net Income$-6,988,350$-2,741,132$-5,332,579$1.45M$-7,332,820$-7,901,619$-8,945,347$-8,530,623$-10,968,874$-10,025,948$-8,275,981$-8,132,115
    EBITDA$-6,822,994$-2,929,784$-5,172,292$1.46M$-7,166,504$-7,698,113$-10,170,231$-8,289,217$-10,084,347$-8,637,299$-7,595,254$-7,297,238
    EBIT$-6,988,350$-3,092,550$-5,332,579$1.30M$-7,323,101$-7,852,393$-10,434,681$-8,549,400$-10,340,056$-8,703,099$-7,667,383$-7,367,422
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VERU

    News

    Veru Inc. - Common Stock (NQ: VERU)

    This page provides a collection of recent news headlines and articles related to Veru Inc. (NASDAQ: VERU), an overview of news from May 2023 to March 2023, covering earnings reports, analyst ratings, stock performance, and company-specific announcements. It highlights events such as Veru missing EPS but beating revenue estimates, the sale of its ENTADFI capsule business, and the FDA's denial of EUA for its Covid-19 treatment which caused a significant stock drop. The articles are sourced from various financial news outlets like InvestorPlace and Benzinga.

    FinancialContent•8/22/26•
    Somewhat-Bearish

    Veru (VERU) Q3 2026 Earnings Call Transcript

    Veru Inc. discussed its Q3 fiscal year 2026 earnings, focusing on the development of enobosarm for "quality weight loss" in older patients with sarcopenic obesity, targeting the preservation of muscle mass while augmenting fat loss. The company announced full enrollment for its Phase IIb PLATEAU clinical trial, a supply agreement with Novo Nordisk for Wegovy, and a newly allowed U.S. patent for enobosarm's method of use in combination with weight loss drugs. Financially, Veru reported a reduced net loss and highlighted increased cash and working capital, projecting sufficient funds beyond the interim analysis of the PLATEAU study in Q1 2027.

    The Globe and Mail•8/18/26•
    Bullish

    Veru (VERU) chief scientist adds 1,800 shares in open-market buy

    Veru Inc.'s Chief Scientific Officer, K. Gary Barnette, purchased 1,800 shares of the company's common stock at an average price of $2.6899 per share on August 13, 2026. This open-market transaction increased his direct holdings to 2,300 shares. The purchase was not conducted under a Rule 10b5-1 trading plan.

    Stock Titan•8/17/26•
    Bullish

    Veru 3Q Loss $6.99M >VERU

    This article reports that Veru (VERU) experienced a third-quarter loss of $6.99 million. The brief financial update indicates the company's performance for the recent fiscal period.

    Moomoo•8/14/26•
    Bearish

    Q3 2026 Veru Inc Earnings Call Transcript

    This article provides the transcript of Veru Inc.'s Q3 2026 earnings call. It includes introductory remarks from the Investor Relations Director and an operator, along with a standard forward-looking statements disclaimer. The full transcript content is gated behind a subscription.

    GuruFocus•8/11/26•
    Neutral

    Frequently Asked Questions About VERU

    Does VERU pay dividends?
    Veru Inc (VERU) has a dividend payment track record. See the VERU dividend history page for its current payment status, yield, and streaks.
    What is VERU's market cap?
    Veru Inc (VERU) has a market capitalization of $44.76M with a current stock price of $2.80.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In